Analyzing Nordic Biotech: News, Performance, Valuations, Big Pharma, Deals and Future Catalysts

We comment recent news flow, indication and phase divided performance, valuations, Big Pharma and deals flow as well as upcoming catalysts in the Nordic Biotech sector.